Health TrialsbyHealthPanel

Vector® System vs Mini-Five Curettes in Non-Surgical Periodontal Therapy

ConditionsPeriodontitisChronic Periodontitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorHacettepe University

About this trial

This randomized clinical trial aims to compare the clinical and radiographic outcomes of the Vector®️ ultrasonic system and mini-five curettes in non-surgical periodontal therapy. Patients diagnosed with periodontitis will be randomly assigned to either ultrasonic instrumentation or manual instrumentation. Clinical periodontal parameters and radiographic bone level changes will be evaluated at baseline, 1, 3, 6, and 12 months. The primary objective is to assess differences in clinical attachment level and probing depth reduction between the two treatment modalities.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Vector® Ultrasonic System

    Device

    Minimally invasive ultrasonic instrumentation used for non-surgical periodontal therapy.

  • Mini-Five Curettes

    Device

    Manual curette instrumentation used for non-surgical periodontal therapy.

Treatment groups

36 Participants
are divided into 2 treatment groups
Group A: Vector System GroupExperimental treatment 1 intervention
Group B: Mini-Five Curettes GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Probing Depth(PD)

Change in periodontal probing depth (in millimeters) from baseline to follow-up after non-surgical periodontal therapy using Vector®️ ultrasonic system compared with mini-five curettes.

Time frame
Baseline,1 month, 3 months, 6 months, and 12 months
2

Change in Radiographic Vertical Bone Defect Depth

Change in radiographic vertical bone defect depth (mm) assessed on standardized radiographs at baseline, 6 months, and 12 months after treatment.

Time frame
Baseline, 6 months, and 12 months

Secondary outcomes

1

Pain Sensitivity(VAS Score)

Pain sensitivity assessed using a visual analog scale (VAS) during and immediately after the treatment session.

Time frame
During treatment and immediately after treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hacettepe University

Lead sponsor

Source ClinicalTrials.gov
Apply now